Mostrar el registro sencillo del ítem

Artículo

dc.creatorServián Morilla, Emiliaes
dc.creatorCabrera Serrano, Macarenaes
dc.creatorCarvajal, A.es
dc.creatorLamont, P.J.es
dc.creatorPelayo Negro, A. L.es
dc.creatorRavenscroft, G.es
dc.creatorJunckerstorff, R.es
dc.creatorDyke, J.Mes
dc.creatorFletcher, S.es
dc.creatorAdams, A. M.es
dc.creatorFernández García, M. A.es
dc.creatorNieto González, José Luises
dc.creatorLaing, N. G.es
dc.creatorRivas, Eloyes
dc.creatorMavillard Saborido, Fabiolaes
dc.creatorParadas, Carmenes
dc.date.accessioned2019-05-24T11:13:46Z
dc.date.available2019-05-24T11:13:46Z
dc.date.issued2019-03-01
dc.identifier.issn2051-5960es
dc.identifier.urihttps://hdl.handle.net/11441/86807
dc.description.abstractTRIM32 is a E3 ubiquitin -ligase containing RING, B-box, coiled-coil and six C-terminal NHL domains. Mutations involving NHL and coiled-coil domains result in a pure myopathy (LGMD2H/STM) while the only described mutation in the B-box domain is associated with a multisystemic disorder without myopathy (Bardet-Biedl syndrome type11), suggesting that these domains are involved in distinct processes. Knock-out (T32KO) and knockin mice carrying the c.1465G > A (p.D489N) involving the NHL domain (T32KI) show alterations in muscle regrowth after atrophy and satellite cells senescence. Here, we present phenotypical description and functional characterization of mutations in the RING, coiled-coil and NHL domains of TRIM32 causing a muscle dystrophy. Reduced levels of TRIM32 protein was observed in all patient muscle studied, regardless of the type of mutation (missense, single amino acid deletion, and frameshift) or the mutated domain. The affected patients presented with variable phenotypes but predominantly proximal weakness. Two patients had symptoms of both muscular dystrophy and Bardet-Biedl syndrome. The muscle magnetic resonance imaging (MRI) pattern is highly variable among patients and families. Primary myoblast culture from these patients demonstrated common findings consistent with reduced proliferation and differentiation, diminished satellite cell pool, accelerated senescence of muscle, and signs of autophagy activation.es
dc.description.sponsorshipHealth Institute Carlos III PI16-01843 JR15/00042es
dc.description.sponsorshipFEDER PI16-01843 JR15/00042es
dc.description.sponsorshipFundación Progreso y Salud, Junta de Andalucía PI-0085-2016es
dc.description.sponsorshipAustralian National Health and Medical Research Council (NHMRC) APP1122952 APP1117510es
dc.formatapplication/pdfes
dc.language.isoenges
dc.publisherSpringer Naturees
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectMuscle dystrophyes
dc.subjectTRIM32es
dc.subjectE3 ubiquitin -ligasees
dc.subjectProliferation/differentiationes
dc.subjectAutophagyes
dc.titleAltered myogenesis and premature senescence underlie human TRIM32-related myopathyes
dc.typeinfo:eu-repo/semantics/articlees
dcterms.identifierhttps://ror.org/03yxnpp24
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationInstituto de Biomedicina de Sevilla (IBIS)es
dc.relation.projectIDPI16-01843es
dc.relation.projectIDJR15/00042es
dc.relation.projectIDPI-0085-2016es
dc.relation.projectIDAPP1122952es
dc.relation.projectIDAPP1117510es
dc.relation.publisherversionhttps://doi.org/10.1186/s40478-019-0683-9es
dc.identifier.doi10.1186/s40478-019-0683-9es
idus.format.extent16 p.es
dc.journaltitleActa Neuropathologica Communicationses
dc.publication.volumen7es
dc.publication.issue1es
dc.publication.initialPage30-1es
dc.publication.endPage30-16es

FicherosTamañoFormatoVerDescripción
Altered-myogenesis-and-prematu ...13.64MbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional